BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37548456)

  • 1. Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report.
    Li ZK; Zheng P
    Int J Clin Pharmacol Ther; 2023 Oct; 61(10):466-470. PubMed ID: 37548456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature.
    Fan Q; Huang W; Weng Y; Xie X; Shi Z
    Medicine (Baltimore); 2020 Oct; 99(43):e22638. PubMed ID: 33120753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline-induced acute pancreatitis in a renal transplant patient: a case report and literature review.
    Lin J; Wang R; Chen J
    BMC Infect Dis; 2018 May; 18(1):201. PubMed ID: 29720098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia.
    Wu X; Zhao P; Dong L; Zhang X
    Medicine (Baltimore); 2017 Dec; 96(49):e9124. PubMed ID: 29245350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pancreatitis caused by tigecycline: A case report and literature review.
    Wang PF; Zou H; Zhu JH; Shi FE
    Medicine (Baltimore); 2021 Dec; 100(51):e28245. PubMed ID: 34941095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tigecycline-associated hypofibrinogenemia in a real-world setting.
    Campany-Herrero D; Larrosa-Garcia M; Lalueza-Broto P; Rivera-Sánchez L; Espinosa-Pereiro J; Mestre-Torres J; Pigrau-Serrallach C
    Int J Clin Pharm; 2020 Aug; 42(4):1184-1189. PubMed ID: 32504166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline-associated acute pancreatitis in a child with pulmonary cystic fibrosis: A case report and literature review.
    Chang C; Qiao W; Wang H; Zhang X
    Int J Clin Pharmacol Ther; 2022 Jan; 60(1):41-45. PubMed ID: 34605395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline-induced acute pancreatitis: case report and literature review.
    Hung WY; Kogelman L; Volpe G; Iafrati M; Davidson L
    Int J Antimicrob Agents; 2009 Nov; 34(5):486-9. PubMed ID: 19540093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study.
    Firat O; Kara E; Malkan ÜY; Demirkan K; Inkaya AÇ
    Thromb Res; 2024 Apr; 236():155-160. PubMed ID: 38452447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute pancreatitis in ICU secondary to treatment with tigecycline.
    Bernas Albeniz A; Aveiga Valencia DA; Etxeberria Zabala L; Zaldibar-Gerrikagoitia Bilbao J; Aguilera Celorrio L
    Rev Esp Anestesiol Reanim; 2017 Jan; 64(1):46-49. PubMed ID: 27609674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder.
    Sabanis N; Paschou E; Gavriilaki E; Kalaitzoglou A; Vasileiou S
    Infect Dis (Lond); 2015; 47(10):743-6. PubMed ID: 25951751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical characteristics of tigecycline-induced acute pancreatitis.
    Fang W; Yi D; Sun L; Wang C
    J Clin Pharm Ther; 2020 Dec; 45(6):1320-1324. PubMed ID: 32649800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study.
    Lin C; Tan M; Wang D; Gu C; Wu Y; Wang S
    Pharmacology; 2023; 108(6):540-549. PubMed ID: 37751720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia.
    Lei H; Liu X; Li Z; Wang C
    J Chemother; 2023 Jul; 35(4):292-297. PubMed ID: 35904191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline-induced acute pancreatitis: about two cases and review of the literature.
    Marot JC; Jonckheere S; Munyentwali H; Belkhir L; Vandercam B; Yombi JC
    Acta Clin Belg; 2012; 67(3):229-32. PubMed ID: 22897076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline-induced acute pancreatitis in a cystic fibrosis patient: A case report and literature review.
    Hemphill MT; Jones KR
    J Cyst Fibros; 2016 Jan; 15(1):e9-11. PubMed ID: 26282838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for tigecycline-induced hypofibrinogenaemia.
    Zhang Q; Wang J; Liu H; Ma W; Zhou S; Zhou J
    J Clin Pharm Ther; 2020 Dec; 45(6):1434-1441. PubMed ID: 32860258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delirium induced by tigecycline treatment for Acinetobacter baumannii infection: A case report.
    Zheng X; Jiang H; Xue L; Qiu F; Zhu S; Li X
    Medicine (Baltimore); 2019 May; 98(19):e15399. PubMed ID: 31083168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatitis in tigecycline Phase 3 and 4 clinical studies.
    McGovern PC; Wible M; Korth-Bradley JM; Quintana A
    J Antimicrob Chemother; 2014 Mar; 69(3):773-8. PubMed ID: 24216769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline-induced life-threatening coagulopathy in a patient with a Mycobacterium abscess: a case report and step-by-step diagnostic approach.
    Akalay S; Vanassche T; De Munter P
    Acta Clin Belg; 2021 Oct; 76(5):410-414. PubMed ID: 32255411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.